HIV Drug Market by Medication class (multi-class combination drugs, nucleoside reverse transcriptase inhibitors (NRTIs), non-nucleoside reverse
|
|
- Hannah Alexander
- 5 years ago
- Views:
Transcription
1 HIV Drug Market by Medication class (multi-class combination drugs, nucleoside reverse transcriptase inhibitors (NRTIs), non-nucleoside reverse transcriptase inhibitors (NNRTIs), protease inhibitors (PIs), fusion inhibitors (FI), entry inhibitors, and HIV integrase stand transfer inhibitors) - Global Opportunity Analysis and Industry Forecast,
2 HIV Drug Market by Medication class (multi-class combination drugs, nucleoside reverse transcriptase inhibitors (NRTIs), non-nucleoside reverse transcriptase inhibitors (NNRTIs), protease inhibitors (PIs), fusion inhibitors (FI), entry inhibitors, and HIV integrase stand transfer inhibitors) - Global Opportunity Analysis and Industry Forecast, BioPortfolio has been marketing business and market research reports from selected publishers for over fifteen years. BioPortfolio offers a personal service to our customers with dedicated research managers who will work with you to source the best report for your needs. Based in the UK, BioPortfolio is well positioned to coordinate our customers' orders sourced from over 50 global report publishers. We are pleased to present details of this report to assist your buying decision and administrative process. You will find easy-to-use How To Buy information on the last page of this document. We look forward to being of service to you. If you have bulk and/or recurring requirements, please get in touch - we can liaise with publishers to obtain sample pages and negotiate discounts on your behalf. Phone: +44 (0) or reportstore@bioportfolio.com 2
3 HIV Drug Market by Medication class (multi-class combination drugs, nucleoside reverse transcriptase inhibitors (NRTIs), non-nucleoside reverse transcriptase inhibitors (NNRTIs), protease inhibitors (PIs), fusion inhibitors (FI), entry inhibitors, and HIV integrase stand transfer inhibitors) - Global Opportunity Analysis and Industry Forecast, Human Immunodeficiency Virus (Hiv) Attacks The Body s Immune System, Making The Host System Susceptible To Infection, And Thus Leading To Complete Damage. The Virus Attacks The Cd4 Cells, Which Help The Immune System Defend Infections. The Major Route Of Transmission Of Hiv Infection Is Through Unprotected Sex, Use Of Contaminated Needle, Breast Milk Of The Hiv Infected Mother, And Infected Blood.nnThe Global Hiv Drugs Market Was Valued At $20,448 Million In 2015, And Is Estimated To Reach $26,458 Million By 2022, Growing At A Cagr Of 3.7% During The Forecast Period From 2016 To The Major Factors That Boost The Growth Of The Market Include Increase In Prevalence Of Hiv Globally And Rise In Treatment & Diagnosis Rate. Moreover, Growth In Awareness About The Treatment Options & Care With The Various Initiatives And Education Campaigns Introduced By Government Agencies Across The Globe Plays An Important Role In The Growth Of Hiv Drugs Market. However, Stringent Government Regulations For The Approval And Commercialization Of Hiv Drugs Is Expected To Restrain The Growth Of The Hiv Drugs Market.nnThe Report Segments The Market Based On Medication Class And Geography. On The Basis Of Medication Class, The Market Is Divided Into Multi-Class Combination Drugs, Nucleoside Reverse Transcriptase Inhibitors (Nrtis), Non-Nucleoside Reverse Transcriptase Inhibitors (Nnrtis), Protease Inhibitors (Pis), Fusion Inhibitors (Fi), Entry Inhibitors, Hiv Integrase Stand Transfer Inhibitors. Based On Geography, The Market Is Analyzed Across North America, Europe, Asia-Pacific, And Lamea. The North American Region Accounted For Around Half Of The Share In The Overall Hiv Drug Market In 2015, And Is Expected To Maintain This Lead Throughout The Forecast Period. The Growth In The Hiv Drug Market In The Region Is Attributed To Well-Established Healthcare System, Higher Diagnosis & Treatment Rate In The Region, And Development And Increase In The Adoption Of Advanced Treatment Options From The Hiv Infected Population.nnKey Benefits for StakeholdersnnnnThe Study Provides An In-Depth Analysis Of The Hiv Drugs Market, With Current Trends And Future Estimations To Elucidate The Imminent Investment Pockets.nnIt Presents A Quantitative Analysis From 2014 To 2022 To Enable The Stakeholders To Capitalize On Prevailing Market Opportunities.nnExtensive Analysis Of The Hiv Drug Market, By Medication Class, Assists In The Effective Treatment Of Hiv/Aids.nnKey Players Are Profiled And Their Strategies Are Analyzed Thoroughly, Which Predicts The Competitive Outlook Of The Market.nnnHIV Drug Market Key SegmentsnnBy Medication ClassnnnnMulti- Class Combination DrugsnnnnnnAtriplannnComplerannnPrezcobix/PrezistannnStribildnnnTriumeqnnnnnnNucleoside Reverse Transcriptase Inhibitors (Nrtis)nnnnnCombivirnnnEmtrivannnEpivirnnnEpzicomnnnTrizivirnnnTruvadannnVireadnnnnnnNon-Nucleoside Reverse Transcriptase Inhibitors (Nnrtis)nnnnnEdurantnnnIntelencennnRescriptornnnSustivannnViramune (Immediate Release)nnnnnnProtease Inhibitors (Pis)nnnnnAptivusnnnCrixivannnnKaletrannnLexivannnNorvirnnnReyataznnnViraceptnnnnnnFusion Inhibitors(Fi)nnnnnFuzeonnnnnnnEntry InhibitorsnnnnnSelzentrynnnnnnHiv Integrase Stand Transfer InhibitorsnnnnnIsentressnnnTivicaynnnnnnnBy GeographynnnnNorth AmericannEuropennAsia- PacificnnLameannnList Of Key Players Profiled in the ReportnnnnBoehringer Ingelheim International GmbhnnMerck & Co.nnBristol-Myers SquibbnnGilead Sciences Inc.nnViiv HealthcarennJohnson & JohnsonnnF. Hoffmann-La Roche Ltd.nnTeva Pharmaceutical Industries Ltd.nnAbbviennCipla LimitednnnList Of Other Players in the Value Chainnnnn(These Players Are Not Profiled In The Report. The Same Will Be Included On Request)nnDaiichi SankyonnEmcurennHetero DrugsnnMylannnAstrazenecan 3
4 Additional Details Publisher : Allied Market Research Reference : LI Number of Pages : 163 Report Format : PDF Publisher Information : 4
5 Table Of Contents for HIV Drug Market by Medication class (multi-class combination drugs, nucleoside reverse transcriptase inhibitors (NRTIs), non-nucleoside reverse transcriptase inhibitors (NNRTIs), protease inhibitors (PIs), fusion inhibitors (FI), entry inhibitors, and HIV integrase stand transfer inhibitors) - Global Opportunity Analysis and Industry Forecast, [Report Updated: ] CHAPTER 1 INTRODUCTION 1.1. REPORT DESCRIPTION 1.2. KEY BENEFITS 1.3. KEY MARKET SEGMENTS 1.4. RESEARCH METHODOLOGY Secondary research Primary research Analyst tools and models CHAPTER 2 EXECUTIVE SUMMARY 2.1. CXO PERSPECTIVE CHAPTER 3 MARKET OVERVIEW 3.1. MARKET DEFINITION AND SCOPE 3.2. KEY FINDINGS Top investment pockets Top winning strategies 3.3. MARKET SHARE ANALYSIS 3.4. PRODUCT PIPELINE ANALYSIS 3.5. MARKET DYNAMICS CHAPTER 4 HIV DRUGS MARKET, BY MEDICATION CLASS 4.1. OVERVIEW 4.2. MULTI-CLASS COMBINATION DRUGS Key market trends Key growth factors and opportunities Market size and forecast Atripla: market size and forecast Complera: market size and forecast Prezista: market size and forecast Stribild: market size and forecast 5
6 Triumeq: market size and forecast 4.3. NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS (NRTIS) Key market trends Key growth factors and opportunities Market size and forecast Combivir: market size and forecast Emtriva: market size and forecast Epivir: market size and forecast Epzicom: market size and forecast Trizivir: market size and forecast Truvada: market size and forecast Viread: market size and forecast 4.4. NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS (NNRTIS) Key market trends Key growth factors and opportunities Market size and forecast Edurant: market size and forecast Rescriptor: market size and forecast Sustiva: market size and forecast Viramune: market size and forecast 4.5. PROTEASE INHIBITORS (PIS) Key market trends Key growth factors and opportunities Market size and forecast Aptivus: market size and forecast Crixivan: market size and forecast Kaletra: market size and forecast Lexiva: market size and forecast Norvir: market size and forecast Reyataz: market size and forecast Viracept: market size and forecast 4.6. FUSION INHIBITORS Key market trends Key growth factors and opportunities Market size and forecast Fuzeon: market size and forecast 4.7. ENTRY INHIBITORS - CCR5 CO-RECEPTOR ANTAGONIST Key market trends Key growth factors and opportunities Market size and forecast Selzentry: market size and forecast 4.8. HIV INTEGRASE STRAND TRANSFER INHIBITORS Key market trends Key growth factors and opportunities 6
7 Market size and forecast Isentress: market size and forecast Tivicay: market size and forecast CHAPTER 5 HIV DRUGS MARKET, BY GEOGRAPHY 5.1. OVERVIEW Market size and forecast 5.2. NORTH AMERICA Key market trends Key growth factors and opportunities Market size and forecast 5.3. EUROPE Key market trends Key growth factors and opportunities Market size and forecast 5.4. ASIA-PACIFIC Key market trends Key growth factors and opportunities Market size and forecast 5.5. LAMEA Key market trends Key growth factors and opportunities Market size and forecast CHAPTER 6 COMPANY PROFILES 6.1. BOEHRINGER INGELHEIM INTERNATIONAL GMBH Overview Operating business segments Business performance Key strategic moves & developments 6.2. MERCK & CO., INC Overview Operating business segments Business performance Key strategic moves & developments 6.3. BRISTOL-MYERS SQUIBB Overview Operating business segments Business performance Key strategic moves & developments 7
8 6.4. GILEAD SCIENCES, INC Overview Operating business segments Business performance Key strategic moves & developments 6.5. VIIV HEALTHCARE Overview Operating business segments Business performance Key strategic moves & developments 6.6. JOHNSON & JOHNSON Overview Operating business segments Business performance Key Strategic Moves & Developments 6.7. F. HOFFMANN-LA ROCHE LTD Overview Operating business segments Business performance Key Strategic Moves & Developments 6.8. TEVA PHARMACEUTICAL INDUSTRIES LTD Overview Operating business segments Business performance Key Strategic Moves & Developments 6.9. ABBVIE Overview Operating business segments Business performance Key strategic moves & developments CIPLA Overview Operating business segments Business performance Key Strategic Moves & Developments LIST OF OTHER PLAYERS IN THE VALUE CHAIN (These players are not profiled in the report. The same will be included on request) Daiichi Sankyo 8
9 Emcure Hetero Drugs Mylan AstraZeneca LIST OF TABLES TABLE 1. HIV PRODUCT PIPELINE: ANTIVIRALS TABLE 2. HIV PRODUCT PIPELINE: CELL THERAPY/GENE THERAPY TABLE 3. HIV PRODUCT PIPELINE: IMMUNOMODULATORS TABLE 4. GLOBAL HIV DRUGS MARKET, BY MEDICATION CLASS, ($MILLION) TABLE 5. GLOBAL MULTI-CLASS COMBINATION DRUGS MARKET, BY GEOGRAPHY, ($MILLION) TABLE 6. GLOBAL MULTI-CLASS COMBINATION DRUGS MARKET, BY BRAND, ($MILLION) TABLE 7. GLOBAL NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS MARKET, BY GEOGRAPHY, ($MILLION) TABLE 8. GLOBAL NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS MARKET, BY BRAND TYPE, ($MILLION) TABLE 9. GLOBAL NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS (NNRTIS) MARKET, BY GEOGRAPHY, ($MILLION) TABLE 10. GLOBAL NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS (NNRTIS) MARKET, BY BRAND TYPE, ($MILLION) TABLE 11. GLOBAL PROTEASE INHIBITORS (PIS) MARKET, BY GEOGRAPHY, ($MILLION) TABLE 12. GLOBAL PROTEASE INHIBITORS (PIS) MARKET, BY BRAND TYPE, ($MILLION) TABLE 13. GLOBAL FUSION INHIBITORS MARKET, BY GEOGRAPHY, ($MILLION) TABLE 14. GLOBAL ENTRY INHIBITORS - CCR5 CO-RECEPTOR ANTAGONIST MARKET, BY GEOGRAPHY, ($MILLION) TABLE 15. GLOBAL HIV INTEGRASE STRAND TRANSFER INHIBITORS MARKET, BY GEOGRAPHY, ($MILLION) TABLE 16. GLOBAL HIV INTEGRASE STRAND TRANSFER INHIBITORS MARKET, BY BRAND TYPE, ($MILLION) TABLE 17. GLOBAL HIV DRUGS MARKET, BY GEOGRAPHY, ($MILLION) TABLE 18. NORTH AMERICA: HIV DRUGS MARKET, BY MEDICATION CLASS, ($MILLION) TABLE 19. EUROPE: HIV DRUGS MARKET, BY MEDICATION CLASS, ($MILLION) TABLE 20. AISA-PACIFIC: HIV DRUGS MARKET, BY MEDICATION CLASS, ($MILLION) TABLE 21. LAMEA: HIV DRUGS MARKET, BY MEDICATION CLASS, ($MILLION) TABLE 22. BOEHRINGER INGELHEIM INTERNATIONAL GMBH: COMPANY SNAPSHOT TABLE 23. BOEHRINGER INGELHEIM: OPERATING SEGMENTS TABLE 24. MERCK: COMPANY SNAPSHOT TABLE 25. MERCK: OPERATING SEGMENTS TABLE 26. BMS: COMPANY SNAPSHOT TABLE 27. GILEAD: COMPANY SNAPSHOT TABLE 28. VIIV HEALTHCARE: COMPANY SNAPSHOT TABLE 29. JOHNSON & JOHNSON: COMPANY SNAPSHOT TABLE 30. JOHNSON & JOHNSON: OPERATING BUSINESS SEGMENTS TABLE 31. ROCHE: COMPANY SNAPSHOT TABLE 32. ROCHE: OPERATING SEGMENTS TABLE 33. TEVA PHARMACEUTICAL: COMPANY SNAPSHOT TABLE 34. TEVA: OPERATING SEGMENTS TABLE 35. ABBVIE: COMPANY SNAPSHOT TABLE 36. CIPLA LIMITED: COMPANY SNAPSHOT LIST OF FIGURES 9
10 FIGURE 1. HIV DRUGS: MARKET SEGMENTATION FIGURE 2. TOP INVESTMENT POCKETS FIGURE 3. TOP WINNING STRATEGIES: PERCENTAGE DISTRIBUTION, FIGURE 4. HIV DRUGS MARKET SHARE ANALYSIS, 2015 FIGURE 5. PRODUCT PIPELINE ANALYSIS FIGURE 6. GLOBAL ATRIPLA MARKET, ($MILLION) FIGURE 7. GLOBAL COMPLERA MARKET, ($MILLION) FIGURE 8. GLOBAL PREZISTA MARKET, ($MILLION) FIGURE 9. GLOBAL STRIBILD MARKET, ($MILLION) FIGURE 10. GLOBAL TRIUMEQ MARKET, ($MILLION) FIGURE 11. GLOBAL COMBIVIR MARKET, ($MILLION) FIGURE 12. GLOBAL EMTRIVA MARKET, ($MILLION) FIGURE 13. GLOBAL EPIVIR MARKET, ($MILLION) FIGURE 14. GLOBAL EPZICOM MARKET, ($MILLION) FIGURE 15. GLOBAL TRIZIVIR MARKET, ($MILLION) FIGURE 16. GLOBAL TRUVADA MARKET, ($MILLION) FIGURE 17. GLOBAL VIREAD MARKET, ($MILLION) FIGURE 18. GLOBAL EDURANT MARKET, ($MILLION) FIGURE 19. GLOBAL INTELENCE MARKET, ($MILLION) FIGURE 20. GLOBAL RESCRIPTOR MARKET, ($MILLION) FIGURE 21. GLOBAL SUSTIVA MARKET, ($MILLION) FIGURE 22. GLOBAL VIRAMUNE MARKET, ($MILLION) FIGURE 23. GLOBAL APTIVUS MARKET, ($MILLION) FIGURE 24. GLOBAL CRIXIVAN MARKET, ($MILLION) FIGURE 25. GLOBAL KALETRA MARKET, ($MILLION) FIGURE 26. GLOBAL LEXIVA MARKET, ($MILLION) FIGURE 27. GLOBAL NORVIR MARKET, ($MILLION) FIGURE 28. GLOBAL REYATAZ MARKET, ($MILLION) FIGURE 29. GLOBAL VIRACEPT MARKET, ($MILLION) FIGURE 30. GLOBAL FUZEON MARKET, ($MILLION) FIGURE 31. GLOBAL SELZENTRY MARKET, ($MILLION) FIGURE 32. GLOBAL ISENTRESS MARKET, ($MILLION) FIGURE 33. GLOBAL TIVICAY MARKET, ($MILLION) FIGURE 34. BOEHRINGER INGELHEIM: REVENUE, ($MILLION) FIGURE 35. MERCK: REVENUE, ($MILLION) FIGURE 36. BMS: REVENUE, ($MILLION) FIGURE 37. GILEAD: REVENUE, ($MILLION) FIGURE 38. JOHNSON & JOHNSON: REVENUE, , ($MILLION) FIGURE 39. ROCHE: REVENUE, , ($MILLION) FIGURE 40. TEVA: REVENUE, , ($MILLION) FIGURE 41. ABBVIE: REVENUE, ($MILLION) FIGURE 42. CIPLA: REVENUE, ($MILLION) 10
11 How to Buy... HIV Drug Market by Medication class (multi-class combination drugs, nucleoside reverse transcriptase inhibitors (NRTIs), non-nucleoside reverse transcriptase inhibitors (NNRTIs), protease inhibitors (PIs), fusion inhibitors (FI), entry inhibitors, and HIV integrase stand transfer inhibitors) - Global Opportunity Analysis and Industry Forecast, [Report Updated: ] Option 1 - Online Go to our website and pay online with any major debit or credit card: Option 2 - Request a Proforma Invoice Fill in the details below, and either Scan this page and it to us at reportstore@bioportfolio.com or Fax it to us at +44 (0) We will send you a Proforma Invoice and deliver your report on settlement. Your Name: Job Title: Your Your Contact Phone: Company Name: Address: Post/Zip Code: Country: P.O. Number: Any Other Instructions: Pricing Options: (please tick one) $5370 Single User Price $5910 Five User License Price $7800 Enterprise License Price Payment Options: (please tick one) Online Credit Card (we will you the invoice with a payment link) Direct Wire Transfer (we will you the invoice with our bank details) Authorising Signature: Option 3 - Phone Us on +44 (0) We will be delighted to give you our personal attention. 11
COPD and Asthma Devices Market by Inhalers Type (Drug powder, Metered Dose, Soft Mist), Nebulizers (Compressor, Ultrasonic, Mesh) - Global
COPD and Asthma Devices Market by Inhalers Type (Drug powder, Metered Dose, Soft Mist), Nebulizers (Compressor, Ultrasonic, Mesh) - Global Opportunity Analysis and Industry Forecasts, 2015-2022 COPD and
More informationStructural Heart Devices Market by Product (Structural Heart Repair Devices and Replacement Valves), Age Group (Pediatric and Adult), and Indication
Structural Heart Devices Market by Product (Structural Heart Repair Devices and Replacement Valves), Age Group (Pediatric and Adult), and Indication (Atrial Septal Defect (ASD), Patent Foramen Ovale (PFO),
More informationImplantable Defibrillators Market by Product Type [Transvenous Implantable Cardioverter-Defibrillator (T-ICDs), Subcutaneous Implantable Cardioverter
Implantable Defibrillators Market by Product Type [Transvenous Implantable Cardioverter-Defibrillator (T-ICDs), Subcutaneous Implantable Cardioverter Defibrillators (S-ICDS), and Cardiac Resynchronization
More informationRussia Cardiac Assist Devices Market Outlook to 2021
Russia Cardiac Assist Devices Market Outlook to 2021 Russia Cardiac Assist Devices Market Outlook to 2021 BioPortfolio has been marketing business and market research reports from selected publishers for
More informationChemotherapy Induced Peripheral Neuropathy Global Clinical Trials Review, H1, 2016
Chemotherapy Induced Peripheral Neuropathy Global Clinical Trials Review, H1, 2016 Chemotherapy Induced Peripheral Neuropathy Global Clinical Trials Review, H1, 2016 BioPortfolio has been marketing business
More informationNorth America Cardiac Rhythm Management (CRM) Procedures Outlook to 2021
North America Cardiac Rhythm Management (CRM) Procedures Outlook to 2021 North America Cardiac Rhythm Management (CRM) Procedures Outlook to 2021 BioPortfolio has been marketing business and market research
More informationSickle-cell Anemia Therapeutics Market in the US
Sickle-cell Anemia Therapeutics Market in the US 2015-2019 Sickle-cell Anemia Therapeutics Market in the US 2015-2019 Sector Publishing Intelligence Limited (SPi) has been marketing business and market
More informationDravet Syndrome (Severe Myoclonic Epilepsy of Infancy) Global Clinical Trials Review, H2, 2015
Dravet Syndrome (Severe Myoclonic Epilepsy of Infancy) Global Clinical Trials Review, H2, 2015 Dravet Syndrome (Severe Myoclonic Epilepsy of Infancy) Global Clinical Trials Review, H2, 2015 BioPortfolio
More informationBariatric Surgery Devices - North America Analysis and Market Forecasts
Bariatric Surgery Devices - North America Analysis and Market Forecasts Bariatric Surgery Devices - North America Analysis and Market Forecasts BioPortfolio has been marketing business and market research
More informationCompetitor Analysis: TGF-? Inhibitors for Modulation of the Tumor Microenvironment
Competitor Analysis: TGF-? Inhibitors for Modulation of the Tumor Microenvironment Competitor Analysis: TGF-? Inhibitors for Modulation of the Tumor Microenvironment BioPortfolio has been marketing business
More informationNon Alcoholic Fatty Liver Disease (NAFLD) - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2018
Non Alcoholic Fatty Liver Disease (NAFLD) - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2018 Non Alcoholic Fatty Liver Disease (NAFLD) - Global API Manufacturers, Marketed and Phase
More informationCompetitor Analysis: IDO & TDO Inhibitors for Modulation of the Tumor Microenvironment
Competitor Analysis: IDO & TDO Inhibitors for Modulation of the Tumor Microenvironment Competitor Analysis: IDO & TDO Inhibitors for Modulation of the Tumor Microenvironment BioPortfolio has been marketing
More informationGlobal Insulin Pumps Market
Global Insulin Pumps Market 2016-2020 Global Insulin Pumps Market 2016-2020 BioPortfolio has been marketing business and market research reports from selected publishers for over fifteen years. BioPortfolio
More informationU.S. Insomnia Market by Non-Pharmacological Therapy (CBTI, Hypnotherapy), Prescription Sleep Aids (Benzodiazepines, Non-Benzodiazepines (Zaleplon),
U.S. Insomnia Market by Non-Pharmacological Therapy (CBTI, Hypnotherapy), Prescription Sleep Aids (Benzodiazepines, Non-Benzodiazepines (Zaleplon), Orexin Antagonist) & OTC Treatment (Antihistamine, Melatonin,
More informationUrinary Incontinence Products Market in Europe
Urinary Incontinence Products Market in Europe 2015-2019 Urinary Incontinence Products Market in Europe 2015-2019 BioPortfolio has been marketing business and market research reports from selected publishers
More informationEUROPE INFERTILITY (TESTING AND TREATMENT) MARKET FORECAST
EUROPE INFERTILITY (TESTING AND TREATMENT) MARKET FORECAST 2017-2025 EUROPE INFERTILITY (TESTING AND TREATMENT) MARKET FORECAST 2017-2025 BioPortfolio has been marketing business and market research reports
More informationAlpha-fetoprotein (AFP) Testing Market: By Cancer Type (Liver Cancer, Testes Cancer, Ovarian Cancer, Biliary Tract Cancer, Stomach Cancer, Pancreatic
Alpha-fetoprotein (AFP) Testing Market: By Cancer Type (Liver Cancer, Testes Cancer, Ovarian Cancer, Biliary Tract Cancer, Stomach Cancer, Pancreatic Cancer, Others (Cirrhosis, and Hepatitis)) & Geography-Forecast
More informationInfertility Treatment Devices Market by Product (Cryosystem, Imaging System, Incubator, Micromanipulator, Ovum Aspiration Pump, Sperm Analyzer,
Infertility Treatment Devices Market by Product (Cryosystem, Imaging System, Incubator, Micromanipulator, Ovum Aspiration Pump, Sperm Analyzer, Workstation), Technology (AI, Gamete Donation, IVF, ICSI,
More informationGlobal In-Vitro-Fertilization Market: Trends and Opportunities ( )
Global In-Vitro-Fertilization Market: Trends and Opportunities (2015-2019) Global In-Vitro-Fertilization Market: Trends and Opportunities (2015-2019) BioPortfolio has been marketing business and market
More informationAntifungal Drugs Market by Drug Type [Echinocandins {Caspofungin, Micafungin, Anidulafungin and Others}, Azoles {Imidazoles, Voricanazole, Thiazoles
Antifungal Drugs Market by Drug Type [Echinocandins {Caspofungin, Micafungin, Anidulafungin and Others}, Azoles {Imidazoles, Voricanazole, Thiazoles and Others}, Polyenes {Amphotericin B, Candicidin, Hamycin,
More informationGlobal Avian Influenza Vaccines Market Data Survey Report 2025
Global Avian Influenza Vaccines Market Data Survey Report 2025 Global Avian Influenza Vaccines Market Data Survey Report 2025 BioPortfolio has been marketing business and market research reports from selected
More informationSilica Fume Market by Application (Building Construction, Marine Structure Construction, Oil & Gas Well Grouting, Nuclear Power Plant Construction,
Silica Fume Market by Application (Building Construction, Marine Structure Construction, Oil & Gas Well Grouting, Nuclear Power Plant Construction, Chemical Production Facilities Construction, by Geography
More informationChina Silymarin Industry Overview,
China Silymarin Industry Overview, 2017-2021 China Silymarin Industry Overview, 2017-2021 BioPortfolio has been marketing business and market research reports from selected publishers for over fifteen
More informationH. Lundbeck AS (LUN) - Financial and Strategic SWOT Analysis Review
H. Lundbeck AS (LUN) - Financial and Strategic SWOT Analysis Review H. Lundbeck AS (LUN) - Financial and Strategic SWOT Analysis Review BioPortfolio has been marketing business and market research reports
More informationAustralia Dental Implants And Prosthetics Market By Implant Material (Titanium, Zirconium), Prosthetic Product (Bridges, Crowns, Dentures), Denture
Australia Dental Implants And Prosthetics Market By Implant Material (Titanium, Zirconium), Prosthetic Product (Bridges, Crowns, Dentures), Denture Type (Partial,Complete), and Abutment Type (Definitive,
More informationAtopic Dermatitis - Japan Drug Forecast and Market Analysis to 2024
Atopic Dermatitis - Japan Drug Forecast and Market Analysis to 2024 Atopic Dermatitis - Japan Drug Forecast and Market Analysis to 2024 BioPortfolio has been marketing business and market research reports
More informationGlobal Vitamin Ingredients Market
Global Vitamin Ingredients Market 2016-2020 Global Vitamin Ingredients Market 2016-2020 BioPortfolio has been marketing business and market research reports from selected publishers for over fifteen years.
More informationDental Floss (Oral Hygiene) Market in South Korea - Outlook to 2020: Market Size, Growth and Forecast Analytics
Dental Floss (Oral Hygiene) Market in South Korea - Outlook to 2020: Market Size, Growth and Forecast Analytics Dental Floss (Oral Hygiene) Market in South Korea - Outlook to 2020: Market Size, Growth
More informationInvisible Orthodontics Market in China
Invisible Orthodontics Market in China 2016-2020 Invisible Orthodontics Market in China 2016-2020 BioPortfolio has been marketing business and market research reports from selected publishers for over
More informationGlobal Hepatitis B and C Diagnostics Market
Global Hepatitis B and C Diagnostics Market 2016-2020 Global Hepatitis B and C Diagnostics Market 2016-2020 BioPortfolio has been marketing business and market research reports from selected publishers
More informationCochlear Implants - Medical Devices Pipeline Assessment, 2016
Cochlear Implants - Medical Devices Pipeline Assessment, 2016 Cochlear Implants - Medical Devices Pipeline Assessment, 2016 BioPortfolio has been marketing business and market research reports from selected
More informationPoland Proton Therapy Market (Actual & Potential), Patients Treated, List of Proton Therapy Centers and Forecast to 2022
Poland Proton Therapy Market (Actual & Potential), Patients Treated, List of Proton Therapy Centers and Forecast to 2022 Poland Proton Therapy Market (Actual & Potential), Patients Treated, List of Proton
More informationCHAPTER FOUR: UPDATE ON THE AIDS PANDEMIC TABLE 2 MILESTONES IN THE HISTORY OF HIV/AIDS TABLE 2 (CONTINUED) REGIONAL OVERVIEW...
CHAPTER ONE: INTRODUCTION... 1 STUDY GOALS AND OBJECTIVES... 1 REASONS FOR DOING THE STUDY... 1 SCOPE OF REPORT... 1 MARKET ANALYSES AND FORECASTS... 2 INTENDED AUDIENCE... 2 INFORMATION SOURCES... 2 ANALYST
More informationProton Therapy Market Outlook - Global Analysis
Proton Therapy Market Outlook - Global Analysis Proton Therapy Market Outlook - Global Analysis BioPortfolio has been marketing business and market research reports from selected publishers for over fifteen
More informationDravet Syndrome (Severe Myoclonic Epilepsy of Infancy) - Pipeline Review, H2 2016
Dravet Syndrome (Severe Myoclonic Epilepsy of Infancy) - Pipeline Review, H2 2016 Dravet Syndrome (Severe Myoclonic Epilepsy of Infancy) - Pipeline Review, H2 2016 BioPortfolio has been marketing business
More informationHIV Drugs and the HIV Lifecycle
HIV Drugs and the HIV Lifecycle Together, we can change the course of the HIV epidemic one woman at a time. #onewomanatatime #thewellproject All HIV drugs work by interrupting different steps in HIV's
More informationPoultry Diagnostics Market by Test (ELISA, PCR) Disease (Avian Salmonellosis, Avian Influenza, Newcastle Disease, Avian Pasteurellosis,
Poultry Diagnostics Market by Test (ELISA, PCR) Disease (Avian Salmonellosis, Avian Influenza, Newcastle Disease, Avian Pasteurellosis, Encephalomyelitis, Infectious Bronchitis), Service (Virology, Bacteriology,
More informationSukhjit Starch And Chemicals Ltd - Company Capsule
Sukhjit Starch And Chemicals Ltd - Company Capsule Sukhjit Starch And Chemicals Ltd - Company Capsule The Business Research Store is run by Sector Publishing Intelligence Ltd. SPi has been selling professional
More informationThe National Institute of Allergy and Infectious Diseases - Pharmaceuticals & Healthcare - Deals and Alliances Profile
The National Institute of Allergy and Infectious Diseases - Pharmaceuticals & Healthcare - Deals and Alliances Profile The National Institute of Allergy and Infectious Diseases - Pharmaceuticals & Healthcare
More informationPhone: +44 (0) or BioPortfolio Limited
Europe Neuromodulation Devices Market by Procedure [Internal Stimulation (DBS, GES, SNS, SCS, VNS), and External Stimulation (TENS, TMS)], and by Geography Analysis & Forecast to 2019 Europe Neuromodulation
More informationAesthetic Laser - Medical Devices Pipeline Assessment, 2016
Aesthetic Laser - Medical Devices Pipeline Assessment, 2016 Aesthetic Laser - Medical Devices Pipeline Assessment, 2016 BioPortfolio has been marketing business and market research reports from selected
More informationPercutaneous Transluminal Angioplasty Balloons - Medical Devices Pipeline Assessment, 2016
Percutaneous Transluminal Angioplasty Balloons - Medical Devices Pipeline Assessment, 2016 Percutaneous Transluminal Angioplasty Balloons - Medical Devices Pipeline Assessment, 2016 BioPortfolio has been
More informationHER2-Negative Breast Cancer - 5EU Drug Forecast and Market Analysis to 2023
HER2-Negative Breast Cancer - 5EU Drug Forecast and Market Analysis to 2023 HER2-Negative Breast Cancer - 5EU Drug Forecast and Market Analysis to 2023 BioPortfolio has been marketing business and market
More informationTandem Diabetes Care, Inc. (TNDM) - Medical Equipment - Deals and Alliances Profile
Tandem Diabetes Care, Inc. (TNDM) - Medical Equipment - Deals and Alliances Profile Tandem Diabetes Care, Inc. (TNDM) - Medical Equipment - Deals and Alliances Profile BioPortfolio has been marketing business
More informationUnited States Proton Therapy Market (Actual & Potential), Patients Treated, List of Proton Therapy Centers and Forecast to 2022
United States Proton Therapy Market (Actual & Potential), Patients Treated, List of Proton Therapy Centers and Forecast to 2022 United States Proton Therapy Market (Actual & Potential), Patients Treated,
More informationDiabetic Neuropathy - Pipeline Review, H1 2017
Diabetic Neuropathy - Pipeline Review, H1 2017 Diabetic Neuropathy - Pipeline Review, H1 2017 BioPortfolio has been marketing business and market research reports from selected publishers for over fifteen
More informationTHE HIV LIFE CYCLE. Understanding How Antiretroviral Medications Work
THE HIV LIFE CYCLE Understanding How Antiretroviral Medications Work DEFINITIONS Host: The animal or cell that another organism lives in. In HIV human CD4 T-cells are the host for HIV. Nucleus: The core
More informationMidwestern Underwriting Conference 2016
UNDERWRITING HIV: THE FAIRY TALE HAS BECOME REALITY Midwestern Underwriting Conference 2016 Jean-Marc Fix, FSA, MAAA VP, R&D, Optimum Re Insurance Co. AGENDA Where are we with HIV? The risk The ideal case
More informationHIV and YOU. Special 2008 Update!
HIV and YOU Special 2008 Update! HIV and You Special 2008 Update! In this booklet, you ll see words in bold, red type. Go to the Glossary on the back cover to find out what these words mean. WRITERS AND
More informationHIV MEDICATIONS AT A GLANCE. Atripla 600/200/300 mg tablet tablet daily. Complera 200/25/300 mg tablet tablet daily
HIV MEDICATIONS AT A GLANCE Generic Name Trade Name Strength DIN Usual Dosage Single Tablet Regimen (STR) Products Efavirenz/ Emtricitabine/ rilpivirine/ elvitegravir/ cobicistat/ alafenamide Emtricitabine/
More informationHuman Papillomavirus Protein E7 (E7) - Pipeline Review, H2 2016
Human Papillomavirus Protein E7 (E7) - Pipeline Review, H2 2016 Human Papillomavirus Protein E7 (E7) - Pipeline Review, H2 2016 Sector Publishing Intelligence Limited (SPi) has been marketing business
More informationWOMENS INTERAGENCY HIV STUDY ANTIRETROVIRAL DOSAGE FORM SECTION A. GENERAL INFORMATION
WOMENS INTERAGENCY HIV STUDY ANTIRETROVIRAL DOSAGE FORM SECTION A. GENERAL INFORMATION A1. PARTICIPANT ID: ENTER NUMBER HERE - - - ONLY IF ID LABEL IS NOT AVAILABLE A2. VISIT #: A3. VERSION DATE: 1 0 /
More informationPharmaPoint: Psoriasis - Global Drug Forecast and Market Analysis to 2024
PharmaPoint: Psoriasis - Global Drug Forecast and Market Analysis to 2024 PharmaPoint: Psoriasis - Global Drug Forecast and Market Analysis to 2024 BioPortfolio has been marketing business and market research
More informationHIV medications HIV medication and schedule plan
Living with HIV (human immunodeficiency virus) It may be scary to find out that you re HIV-positive or have AIDS. Coping with this news may be difficult. Although HIV is a serious infection, people with
More informationPharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024
PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024 PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market
More informationAsia-Pacific In-Vitro Fertilization (IVF) Services Market by Cycle Type (Fresh Cycle, Thawed IVF Cycle, and Donor Egg IVF Cycles) and End Users
Asia-Pacific In-Vitro Fertilization (IVF) Services Market by Cycle Type (Fresh Cycle, Thawed IVF Cycle, and Donor Egg IVF Cycles) and End Users (Fertility Clinics, Hospitals, Surgical Centres, and Clinical
More informationBrochure More information from
Brochure More information from http://www.researchandmarkets.com/reports/2375238/ Breast Imaging Technologies Market (Digital Mammography,3D Breast Tomosynthesis, Breast MRI, Breast Ultrasound, Molecular
More informationKaletra (HIV) Forecast and Market Analysis to GDHC1051DFR/ Published January 2013
Kaletra (HIV) Forecast and Market Analysis to 2022 GDHC1051DFR/ Published January 2013 Executive Summary Kaletra Key Metrics in the Nine Major Pharmaceutical Markets 2012 Market Sales US - Kaletra 5EU
More informationWOMEN'S INTERAGENCY HIV STUDY METABOLIC STUDY: MS01 SPECIMEN COLLECTION FORM
WOMEN'S INTERAGENCY HIV STUDY METABOLIC STUDY: MS01 SPECIMEN COLLECTION FORM ID LABEL HERE ---> VERSION DATE 10/01/07 - - - VISIT #: FORM COMPLETED BY: A1. DATE OF BLOOD DRAW: / / M D Y A2. Do you take
More informationOB/GYN CHART REVIEW DRAFT: NOT FOR DISTRTIBUTION
OB/GYN CHART REVIEW A summary of OB/GYN clinical chart review results designed to monitor the quality of care provided by a Ryan White funded OB/GYN primary care site as part of the Atlanta EMA s quality
More informationGenotyping and Drug Resistance in Clinical Practice. Case Studies
Genotyping and Drug Resistance in Clinical Practice Case Studies 12/02 40 year old Hispanic male Dx with HIV 1995 + Hx of PCP > 1x, HepC Medication history: AZT, Crixivan, Videx EC, Sustiva, Zerit, Ziagen,
More informationPage 1 of 5 ENLGLISH / ESPAÑOL / PORTUGUÉS / FRANÇAIS Share 3 Drug Chart for HIV Treatment CURRENT EDITION ABOUT SENSE BACK ISSUES MSMGF HOME CONTACT US There are a number of antiretroviral (ARV) medications
More informationAntiretrovial Crushable/Liquid Formulation Chart
Antiretrovial Crushable/Liquid Formulation Chart Eliza Dollard, PharmD; Nafeesa Chin-Beckford, PharmD; Laura Aragon, PharmD Last Updated: 04/2016 Agent How Supplied Crushable Status **Products listed in
More informationInsulin Pens - Medical Devices Pipeline Assessment, 2016
Insulin Pens - Medical Devices Pipeline Assessment, 2016 Insulin Pens - Medical Devices Pipeline Assessment, 2016 Sector Publishing Intelligence Limited (SPi) has been marketing business and market research
More informationVisceral Pain Market Share, Size, Analysis, Growth, Industry Trends and Forecasts to 2024 Hexa Research
Visceral Pain Market Share, Size, Analysis, Growth, Industry Trends and Forecasts to 2024 Hexa Research The global visceral pain market size was estimated at USD 9.51 billion in 2016 and is expected to
More informationOncology Pipeline Analytics
Oncology Pipeline Analytics Trials, Drug Classes, Indications, Correlations and Strategies Report Brochure O n c o l o g y P i p e l i n e A n a l y t i c s Greystone Research Associates is pleased to
More informationAn HIV Update Jan Clark, PharmD Specialty Practice Pharmacist
An HIV Update - 2019 Jan Clark, PharmD Specialty Practice Pharmacist 2 The goal of this program is to provide a review and update of HIV care and to provide a forum for discussing the current local and
More informationMEDICAL COVERAGE GUIDELINES ORIGINAL EFFECTIVE DATE: 03/07/18 SECTION: DRUGS LAST REVIEW DATE: 02/19/19 LAST CRITERIA REVISION DATE: ARCHIVE DATE:
FUZEON (enfuvirtide) Non-Discrimination Statement and Multi-Language Interpreter Services information are located at the end of this document. Coverage for services, procedures, medical devices and drugs
More informationPRO 140. First self-administered antibody therapy for HIV in late-stage clinical development. March
PRO 140 First self-administered antibody therapy for HIV in late-stage clinical development March 2018 Forward-Looking Statements This presentation includes forward-looking statements and forward-looking
More informationDIAGNOSTICS AND THERAPEUTICS FOR HIV: GLOBAL MARKETS
DIAGNOSTICS AND THERAPEUTICS FOR HIV: GLOBAL MARKETS PHM058B April 2014 Kritika Chaudhari Project Analyst ISBN: 1-56965-767-X BCC Research 49 Walnut Park, Building 2 Wellesley, MA 02481 USA 866-285-7215
More informationCHAPTER ONE: EXECUTIVE SUMMARY
CHAPTER ONE: EXECUTIVE SUMMARY Introduction Scope and Methodology Total Size and Growth of the Market Issues and Trends Affecting Market Leading Competitors CHAPTER TWO: INTRODUCTION AND INDUSTRY TRENDS
More informationHIV Management Update 2015
9/30/15 HIV Management Update 2015 Larry Pineda, PharmD, PhC, BCPS Visiting Assistant Professor Pharmacy Practice and Administrative Science ljpineda@salud.unm.edu Pharmacist Learning Objectives Describe
More informationNorthwest AIDS Education and Training Center Educating health care professionals to provide quality HIV care
Northwest AIDS Education and Training Center Educating health care professionals to provide quality HIV care www.nwaetc.org The Northwest AIDS Education and Training Center (NW AETC), located at the University
More informationGlobal Skin Cancer Diagnosis and Therapeutics Market Research and Forecast
Report Information More information from: https://www.wiseguyreports.com/reports/3186925-global-skin-cancer-diagnosis-and-therapeuticsmarket-research Global Skin Cancer Diagnosis and Therapeutics Market
More informationDaclatasvir (Daklinza ) Drug Interactions with HIV Medications
Daclatasvir/Sofosbuvir (Daklinza /Sovaldi TM ) Drug Interactions A Quick Guide for Clinicians April 2017 John J Faragon, PharmD, BCPS, AAHIVP Mechanism of Action and Route of Metabolism for Daclatasvir
More informationCystic Fibrosis: KOL Insight [2017]
Cystic Fibrosis: KOL Insight [2017] Cystic Fibrosis: KOL Insight [2017] BioPortfolio has been marketing business and market research reports from selected publishers for over fifteen years. BioPortfolio
More informationHIV THERAPY STRATEGIES FOR THIRD LINE. issues to consider when faced with few drug options
STRATEGIES FOR THIRD LINE HIV THERAPY issues to consider when faced with few drug options A PUBLICATION FROM Information, Inspiration and Advocacy for People Living With HIV/AIDS MAY 2008 Most people living
More informationMay 2016 P & T Updates
Commercial Triple Tier 4th Tier Applicabl e Traditional Detailed s 2 films - DESCOVY 2 2 1 tablet NARCAN 2 2 ODEFSEY 2 2 1 tablet REPATHA 2 2 HoFH: 3 ml per 28 ROSUVASTATIN 1 1 - UPTRAVI 3 2 - Alternatives
More informationInfluenza Vaccination Market Research Report Global Forecast till 2023
Report Information More information from: https://www.marketresearchfuture.com/reports/1621 Influenza Vaccination Market Research Report Global Forecast till 2023 Report / Search Code: MRFR/HC/1090-HCRR
More informationFluconazole dimenhydrinate, diphenhydramine. Raltegravir or dolutegravir with antacids
Supportive therapy Summary of interactions Table 1. Summary of potential interactions between antiretroviral agents and supportive therapy Interactions with enzyme inhibitors (protease inhibitors and elvitegravir/cobicistat)
More informationHIV Treatment Guidelines
HIV Treatment Guidelines Together, we can change the course of the HIV epidemic one woman at a time. #onewomanatatime #thewellproject What Are Treatment Guidelines? Issued by variety of global and country-based
More informationSpinal Cord Injury - Pipeline Review, H2 2016
Spinal Cord Injury - Pipeline Review, H2 2016 BioPortfolio has been marketing business and market research reports from selected publishers for over fifteen years. BioPortfolio offers a personal service
More informationGlobal HPV Vaccine Market: Analysis By End-User (Male, Female), By Age Group (Adolescents, Adults) - By Region, By Country ( )
Global HPV Vaccine Market: Analysis By End-User (Male, Female), By Age Group (Adolescents, Adults) - By Region, By Country (2017-2022) By Region- North America, Europe, APAC and RoW By Country - United
More informationSegment Coverage By Type By Age Group. Global Coverage Regional Coverage Country Coverage
Global Cervical Cancer Diagnostics Market By Type (Pap Testing, HPV Testing, Colposcopy and Cervical Biopsies), By Age Group (35 years): Forecast to 2022 By Type - Pap Test, HPV Test,
More informationHuman Immunodeficiency Virus (HIV) and Acquired Immune Deficiency Syndrome (AIDS) in the Long Term Care Setting Part 2: HIV Medications
Human Immunodeficiency Virus (HIV) and Acquired Immune Deficiency Syndrome (AIDS) in the Long Term Care Setting Part 2: HIV Medications Carrie Allen PharmD, CGP, BCPS, BCPP, CCHP Overview - Part 2: HIV
More informationHIV THERAPY STRATEGIES FOR FIRST LINE. issues to think about when going on therapy for the first time
STRATEGIES FOR FIRST LINE HIV THERAPY issues to think about when going on therapy for the first time A PUBLICATION FROM Information, Inspiration and Advocacy for People Living With HIV/AIDS MAY 2008 Deciding
More informationImplantable Cardioverter Defibrillators (ICD) - Medical Devices Pipeline Assessment, 2016
Implantable Cardioverter Defibrillators (ICD) - Medical Devices Pipeline Assessment, 2016 Implantable Cardioverter Defibrillators (ICD) - Medical Devices Pipeline Assessment, 2016 BioPortfolio has been
More informationGlobal Coverage. Regional Coverage. Company Coverage. Country Coverage. Global Coverage Regional Coverage Country Coverage
Global Influenza Drugs and Vaccines Market By Drugs (Zanamivir, Oseltamivir Phosphate, Peramivir), By Vaccine (Trivalent, Quadrivalent): Analysis By Region, By Country: Opportunities and Forecast (2016-2021)
More informationtreatment passport 1
treatment passport 1 Why keep a treatment history? Keeping a short record of your treatment history can help in many ways. It can help you understand your health and treatment. It can help if your doctor
More informationeclinical Solutions Market Share, Size, Analysis, Growth, Trends and Forecasts to 2024 Hexa Research
eclinical Solutions Market Share, Size, Analysis, Growth, Trends and Forecasts to 2024 Hexa Research " Projected to grow at a CAGR of around 12%, eclinical solutions market is expected to witness significant
More informationph Meters Market Share, Size, Analysis, Growth, Trends and Forecasts to 2024 Hexa Research
ph Meters Market Share, Size, Analysis, Growth, Trends and Forecasts to 2024 Hexa Research " The ph meters market is expected to grow at a CAGR of 3% over the forecast period from 2016 to 2024." 31 October
More informationBlood Flow Measurement Devices Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, Single User License: US $ 4595
Transparency Market Research Blood Flow Measurement Devices Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013-2019 Single User License: US $ 4595 Buy Now Request Sample
More informationUltrasound Device Market - Industry Analysis, Size, Share, Growth and Forecasts to Hexa Research
Ultrasound Device Market - Industry Analysis, Size, Share, Growth and Forecasts to 2024 - Hexa Research " The global ultrasound device market was valued at approximately USD 6.8 billion and it is projected
More informationHypodermic Needles Market Analysis, Size, Share, Growth, Industry Trends and Forecasts to Hexa Research
Hypodermic Needles Market Analysis, Size, Share, Growth, Industry Trends and Forecasts to 2024 - Hexa Research " The global hypodermic needles market was estimated at USD 2,568.7 million in 2016. The primary
More informationOctober 26-28: Training Day 1
Peer Linkage and Re-Engagement of HIV- Positive Women of Color October 26-28: Training Day 1 Peer Linkage and Re -Engagement of HIV - Positive Women of Color Convening Training Trainers Today: Alicia Downes
More informationMedical Morphine Market Size, Share, Growth, Analysis, Trends, and Forescast to 2024 Hexa Research
Medical Morphine Market Size, Share, Growth, Analysis, Trends, and Forescast to 2024 Hexa Research Increasing use of the drug to relieve pain in cancer, arthritis and postoperative surgeries is expected
More informationNoninvasive Glucose Monitors to 2022
Noninvasive Glucose Monitors to 2022 Devices, Technologies, Players and Prospects Report Prospectus Greystone Research associates N o n i n v a s i v e G l u c o s e M o n i t o r s t o 2 0 2 2 Greystone
More informationACTHIV 2018: A State-of-the-Science Conference for Frontline Health Professionals
Antiretroviral Medications: What you need to know Jason J. Schafer, PharmD, MPH, BCPS, AAHIVP Associate Professor, Department of Pharmacy Practice Jefferson College of Pharmacy, Thomas Jefferson University
More informationOligonucleotide Testing Market Analysis, Size, Share, Growth, Industry Trends and Forecast to 2024 Hexa Research
Oligonucleotide Testing Market Analysis, Size, Share, Growth, Industry Trends and Forecast to 2024 Hexa Research Oligonucleotide Testing Market is expected to witness a significant growth, pertaining to
More information